NEU

0.75%

$1.34

NEUREN PHARMACEUTICALS LIMITED

Market Cap $137.5M Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Latest Threads

Tag

Subject

NEU

Institutions increase stakes in ACADIA

01:22

219

01:22

Last post Ridge1

219

NEU

Ann: New patent granted for Neuren's NNZ-2591 in Japan

19/08/19

46K

19/08/19

Last post Melchior

46K

NEU

News: NEU Neuren Pharmaceuticals Granted New Patent By Japan Patent Office For Nnz-2591

16/08/19

838

16/08/19

Last post

Hot News

838

NEU

Price Movement

2 3

14/08/19

167

75K

14/08/19

Last post Little T

167

75K

NEU

Lanstead Selling .

08/08/19

114

41K

08/08/19

Last post jimbovb

114

41K

NEU

Its been a while...

05/08/19

1.6K

05/08/19

Last post What A Gas

1.6K

NEU

Lavender Update

02/08/19

6.4K

02/08/19

Last post lilypily

6.4K

NEU

Ann: Appendix 4C - quarterly

31/07/19

591

31/07/19

Last post

ASX News

591

See All Discussions

Timeline

New patent granted for Neuren's NNZ-2591 in Japan
16 Aug 09:46	Share

Appendix 4C - quarterly
31 Jul 16:22	Share

Neuren submits 3 NNZ-2591 Orphan Drug applications to FDA
29 Jul 09:11	Share

Neuren receives final payment from Lanstead Capital
16 Jul 09:36	Share

Results of Meeting
28 May 15:42	Share

Chairman's Address at 2019 Annual Meeting of Shareholders
28 May 14:39	Share

Validation for NNZ-2591 neurodevelopmental disorder pipeline
17 May 10:02	Share

NNZ-2591 positive effects in Pitt Hopkins syndrome model
17 May 09:56	Share

NNZ-2591 positive effects in Angelman syndrome model
17 May 09:54	Share

Appendix 4C - quarterly
30 Apr 16:36	Share

Notice of Annual General Meeting/Proxy Form
29 Apr 13:30	Share

Appendix 4G
26 Apr 10:03	Share

Annual Report to shareholders
26 Apr 10:02	Share

Update on development plan for NNZ-2591
26 Apr 09:59	Share

Neuren's Rett syndrome Phase 2 trial published in Neurology
28 Mar 08:11	Share

Fundamentals strong as Neuren advances neuroscience pipeline
27 Feb 17:03	Share

Preliminary Final Report and statutory accounts
27 Feb 16:56	Share

NNZ-2591 positive effects in Phelan-McDermid syndrome model
18 Feb 09:19	Share

Plans for Phase 3 trial in Rett syndrome
04 Feb 09:51	Share

Neuren retains ex-North America, appoints investment bank
01 Feb 09:14	Share

Appendix 4C - quarterly
31 Jan 17:41	Share

Final Director's Interest Notice
03 Jan 16:56	Share

Ceasing to be a substantial holder
31 Dec 08:23	Share

2018 Year-end Business Update
18 Dec 09:45	Share

Larry Glass to retire as a director and continue as CSO
17 Dec 12:25	Share

Presentation at AusBiotech Invest and Partnering 2018
02 Nov 12:44	Share

Appendix 4C - quarterly
31 Oct 14:59	Share

Trofinetide ex-North America exclusive negotiation period
26 Oct 09:44	Share

Neuren and ACADIA hold Rett syndrome SAB meeting
17 Oct 09:31	Share

Change of Director's Interest Notice
01 Oct 09:31	Share

View More

(20min delay) Trade with IG
Last $1.34		Change 0.010(0.75%)		Mkt cap ! $137.5M

Open	High	Low	Value	Volume
$1.33	$1.35	$1.28	$55.12K	42.00K

Buyers (Bids)

No.	Vol.	Price($)
1	6500	$1.28

Sellers (Offers)

Price($)	Vol.	No.
$1.34	12010	2

View Market Depth

No.	Vol.	Price($)
1	6500	1.280
1	7000	1.265
1	10000	1.260
2	2400	1.250
1	3000	1.240

Price($)	Vol.	No.
1.340	12010	2
1.350	6340	1
1.370	2391	1
1.400	3750	2
1.430	7000	1

Last update - 16.10pm 19/08/2019 (20 minute delay)

(live)
Last $1.31		Change 0.010 ( 1.14 %)
Open	High	Low	Volume
$1.32	$1.32	$1.27	9288
Last updated 13.08pm 19/08/2019 (live) ?

NEU (ASX) Chart